Filed before 2025Filed 31 May 2018
Cortexyme, Inc. raised $84.5M
Cortexyme, Inc., a pharmaceuticals company based in South San Francisco, CA, raised $84.5M in a new equity round, according to a filing dated 31 May 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 31 May 2018
- Round
- Equity round
- Amount sold
- $84.5M
- Offering size
- $85.6M
- Investors so far
- 36
- Based in
- South San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 96% of the 1,729 tracked raises with an amount filed in 2018, and than 100% of the 42 in pharmaceuticals.
Cortexyme, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 11 Jun 2026 | New filing | — | Not tracked |
| 11 Jun 2026 | New filing | $115M | Not tracked |
| 31 May 2018 | New filing | $84.5M | This raise |
| 14 Feb 2017 | New filing | $7.6M | Another raise |
| 5 Jan 2016 | New filing | $7.92M | Another raise |
More with Aditum Bio on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.